Endothelial Facilitation in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
VI-1121 for the Treatment Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- NA
Alzheimer's Disease Core Center
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
- Status
- COMPLETED
- Phase
- PHASE2
The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil
- Status
- COMPLETED
- Phase
- PHASE1
Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
- Status
- UNKNOWN
- Phase
- N/A
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
[18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002)
- Status
- TERMINATED
- Phase
- PHASE1
Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
- Status
- COMPLETED
- Phase
- NA
iCare Stress Management e-Training for Dementia Family Caregivers
- Status
- COMPLETED
- Phase
- PHASE2
3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2